Globus Medical Total Assets 2010-2024 | GMED

Globus Medical total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Globus Medical total assets for the quarter ending September 30, 2024 were $5.086B, a 5.04% decline year-over-year.
  • Globus Medical total assets for 2023 were $5.086B, a 144.98% increase from 2022.
  • Globus Medical total assets for 2022 were $2.076B, a 6.07% increase from 2021.
  • Globus Medical total assets for 2021 were $1.957B, a 16.54% increase from 2020.
Globus Medical Annual Total Assets
(Millions of US $)
2023 $5,086
2022 $2,076
2021 $1,957
2020 $1,679
2019 $1,532
2018 $1,301
2017 $1,079
2016 $928
2015 $834
2014 $704
2013 $566
2012 $447
2011 $329
2010 $267
2009 $0
Globus Medical Quarterly Total Assets
(Millions of US $)
2024-09-30 $5,086
2024-06-30 $4,994
2024-03-31 $4,944
2023-12-31 $5,086
2023-09-30 $5,356
2023-06-30 $2,212
2023-03-31 $2,150
2022-12-31 $2,076
2022-09-30 $1,977
2022-06-30 $1,915
2022-03-31 $1,999
2021-12-31 $1,957
2021-09-30 $1,911
2021-06-30 $1,830
2021-03-31 $1,738
2020-12-31 $1,679
2020-09-30 $1,542
2020-06-30 $1,466
2020-03-31 $1,479
2019-12-31 $1,532
2019-09-30 $1,452
2019-06-30 $1,391
2019-03-31 $1,336
2018-12-31 $1,301
2018-09-30 $1,239
2018-06-30 $1,194
2018-03-31 $1,128
2017-12-31 $1,079
2017-09-30 $1,037
2017-06-30 $995
2017-03-31 $960
2016-12-31 $928
2016-09-30 $902
2016-06-30 $869
2016-03-31 $840
2015-12-31 $834
2015-09-30 $801
2015-06-30 $765
2015-03-31 $744
2014-12-31 $704
2014-09-30 $646
2014-06-30 $618
2014-03-31 $599
2013-12-31 $566
2013-09-30 $525
2013-06-30 $498
2013-03-31 $474
2012-12-31 $447
2012-09-30 $416
2012-06-30 $367
2012-03-31 $355
2011-12-31 $329
2011-09-30 $0
2011-06-30 $0
2011-03-31 $0
2010-12-31 $267
2009-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $11.200B $1.568B
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $214.078B 26.12
Intuitive Surgical (ISRG) United States $183.628B 96.01
Alcon (ALC) Switzerland $45.117B 31.76
IQVIA Holdings (IQV) United States $40.157B 22.12
Edwards Lifesciences (EW) United States $39.608B 24.62
IDEXX Laboratories (IDXX) United States $34.672B 40.83
DexCom (DXCM) United States $26.799B 40.36
Waters (WAT) United States $22.960B 33.95
STERIS (STE) Ireland $22.437B 25.85
SONOVA HOLDING (SONVY) Switzerland $21.922B 0.00
Hologic (HOLX) United States $18.696B 19.73
Fresenius Medical Care AG KGaA (FMS) Germany $12.376B 12.70
Sysmex ADR (SSMXY) Japan $11.851B 37.16
Teleflex (TFX) United States $9.378B 14.96
Penumbra (PEN) United States $8.969B 87.86
Masimo (MASI) United States $8.917B 43.43
Glaukos (GKOS) United States $7.755B 0.00
PROCEPT BioRobotics (PRCT) United States $5.126B 0.00
Integer Holdings (ITGR) United States $4.542B 25.75
Inari Medical (NARI) United States $3.119B 0.00
TransMedics (TMDX) United States $2.898B 91.86
LivaNova (LIVN) United Kingdom $2.829B 16.33
Veracyte (VCYT) United States $2.811B 85.09
Nihon Kohden (NHNKY) Japan $2.519B 15.68
Tandem Diabetes Care (TNDM) United States $2.242B 0.00
Elekta AB (EKTAY) Sweden $2.227B 18.14
Integra LifeSciences Holdings (IART) United States $2.060B 10.77
RxSight (RXST) United States $2.024B 0.00
Alphatec Holdings (ATEC) United States $1.257B 0.00
Artivion (AORT) United States $1.233B 113.23
Pulse Biosciences (PLSE) United States $1.110B 0.00
OPKO Health (OPK) United States $1.025B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.963B 16.37
OrthoPediatrics (KIDS) United States $0.749B 0.00
Mesa Laboratories (MLAB) United States $0.726B 18.33
Pacific Biosciences Of California (PACB) United States $0.722B 0.00
IRadimed (IRMD) United States $0.712B 38.49
ORTHOFIX MEDICAL INC (OFIX) United States $0.702B 0.00
AxoGen (AXGN) United States $0.672B 0.00
SiBone (SIBN) United States $0.669B 0.00
Paragon 28 (FNA) United States $0.605B 0.00
Treace Medical Concepts (TMCI) United States $0.485B 0.00
CVRx (CVRX) United States $0.374B 0.00
ClearPoint Neuro (CLPT) United States $0.369B 0.00
Tactile Systems Technology (TCMD) United States $0.351B 18.99
Delcath Systems (DCTH) United States $0.304B 0.00
AngioDynamics (ANGO) United States $0.301B 0.00
Semler Scientific (SMLR) United States $0.291B 19.57
Sight Sciences (SGHT) United States $0.257B 0.00
NeuroPace (NPCE) United States $0.228B 0.00
Inogen (INGN) United States $0.227B 0.00
Nevro (NVRO) United States $0.216B 0.00
Accuray (ARAY) United States $0.204B 0.00
Atossa Genetics (ATOS) United States $0.186B 0.00
Alpha Tau Medical (DRTS) Israel $0.160B 0.00
908 Devices (MASS) United States $0.136B 0.00
KORU Medical Systems (KRMD) United States $0.129B 0.00
Spectral Diagnostics (EDTXF) Canada $0.116B 0.00
Sensus Healthcare (SRTS) United States $0.110B 16.32
EDAP TMS S.A (EDAP) France $0.105B 0.00
WORK Medical Technology Group (WOK) China $0.087B 0.00
Monogram Orthopaedics (MGRM) United States $0.077B 0.00
Hyperfine (HYPR) United States $0.070B 0.00
LENSAR (LNSR) United States $0.068B 0.00
Covalon Technologies (CVALF) Canada $0.068B 0.00
InspireMD (NSPR) Israel $0.061B 0.00
EnVVeno Medical (NVNO) United States $0.060B 0.00
Lucid Diagnostics (LUCD) United States $0.051B 0.00
Rapid Micro Biosystems (RPID) United States $0.049B 0.00
Accelerate Diagnostics (AXDX) United States $0.047B 0.00
Vicarious Surgical (RBOT) United States $0.046B 0.00
Envoy Medical (COCH) United States $0.038B 0.00
Neuronetics (STIM) United States $0.036B 0.00
Adagio Medical Holdings (ADGM) United States $0.036B 0.00
DarioHealth (DRIO) United States $0.030B 0.00
Precision Optics (POCI) United States $0.029B 0.00
Spectral AI (MDAI) United States $0.028B 0.00
Biosig Technologies (BSGM) United States $0.028B 0.00
Ekso Bionics Holdings (EKSO) United States $0.020B 0.00
Baird Medical Investment Holdings (BDMD) $0.019B 0.00
NexGel (NXGL) United States $0.018B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.016B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
Autonomix Medical (AMIX) United States $0.015B 0.00
Aspira Women's Health (AWH) United States $0.014B 0.00
QT Imaging Holdings (QTI) United States $0.012B 0.00
Pixie Dust Technologies (PXDT) Japan $0.012B 0.00
T2 Biosystems (TTOO) United States $0.012B 0.00
PAVmed (PAVM) United States $0.011B 0.00
Check-Cap (CHEK) Israel $0.007B 0.00
ENDRA Life Sciences (NDRA) United States $0.004B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00